Pharmacists in Bellevue, KY Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Dr. Alex Klingenbeck, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 53 Donnermeyer Dr, Bellevue, KY 41073 Phone: 859-431-5413 |
 Joy Ann Cunningham, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Landmark Dr, Ste 103, Bellevue, KY 41073 Phone: 859-291-8665 |
Dr. Michelle Watters, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Landmark Dr, Bellevue, KY 41073 Phone: 859-291-8665 |
Mrs. Jessica Ann Hemmer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 53 Donnermeyer Dr, Bellevue, KY 41073 Phone: 859-431-5413 |
Mrs. Tracy Jennings, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 53 Donnermeyer Dr, Bellevue, KY 41073 Phone: 859-431-5413 Fax: 859-491-0302 |
News Archive
Mayo Clinic research shows RA patients more likely to develop chronic kidney disease
Rheumatoid arthritis patients are likelier than the average person to develop chronic kidney disease, and more severe inflammation in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity are among the risk factors, new Mayo Clinic research shows.
Many patients continue working after metastatic cancer diagnosis, study finds
A new analysis indicates that many patients continue working after being diagnosed with metastatic cancer, but a heavy burden of symptoms may prevent them from doing so. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study illustrates the need to treat difficult symptoms so that patients can maintain their employment.
Half of consumer-directed health plan enrollees say they would be likely to switch plans if given the opportunity
Half of individuals enrolled in consumer-directed plans said they would switch out of the plans if given the opportunity, while about one-third of enrollees in more traditional employer-sponsored health plans said they would change their coverage if they had the chance, according to a survey released on Thursday.
Celgene announces data from REVLIMID plus rituximab Phase II study on malignant lymphomas
Celgene International Sàrl announced that clinical data from a Phase II study, conducted by investigators from the MD Anderson Cancer Center in Houston, TX, evaluating the combination regimen of REVLIMID plus rituximab (R2) in untreated, advanced stage, indolent B-cell non-Hodgkin's lymphomas, were presented at the 11th International Conference on Malignant Lymphoma in Lugano, Switzerland.
The Replikin Count of H1N1 virus's infectivity gene shows continued elevation
The latest H1N1 genomic data shows a 50% drop in the Replikin CountTM of the virus's replikins lethality gene since its recorded highs in April 2009. In contrast, the Replikin Count of the virus's infectivity gene showed a continued elevation.
› Verified 8 days ago
Clinical Social Workers
Pharmacists
Dentists
Counselors
Psychologists